Filing Details

Accession Number:
0001209191-16-122282
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-05-20 17:37:55
Reporting Period:
2016-05-19
Filing Date:
2016-05-20
Accepted Time:
2016-05-20 17:37:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1594864 Juno Therapeutics Inc. JUNO () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1398322 J Bernard Cassidy C/O 307 Westlake Avenue N Ste 300
Seattle WA 98109
General Counsel & Secretary No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-05-19 2,239 $38.77 55,511 No 4 S Direct
Common Stock Disposition 2016-05-19 877 $39.69 54,634 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 26,869 Indirect By Morgan Stanley Smith Barney LLC as Custodian for Bernard Cassidy IRA
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, in which the shares were sold through a trust for the sole benefit of the reporting person and his spouse.
  2. This transaction was executed in multiple trades at prices ranging from $38.35 to $39.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. Includes 467 shares acquired under the issuer's employee stock purchase plan on May 16, 2016.
  4. This transaction was executed in multiple trades at prices ranging from $39.35 to $40.28. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.